Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Feb / AI in Glaucoma
Glaucoma

AI in Glaucoma

First industry-led glaucoma symposium explores the transformative role of artificial intelligence

By The Ophthalmologist 2/24/2025 1 min read

Share

Credit: Heidelberg Engineering

The expected burden on global healthcare systems of glaucoma care in the next decade was the focus of the first Heidelberg Engineering International Glaucoma Symposium, held at the University Eye Clinic in Mainz, Germany on February 1, 2025. 
The event brought the role of AI to the fore, with delegates from 13 countries discussing the expected next steps in integrating this safely into care pathways.

“Global experts explored the transformative role of AI in ophthalmology, clinical practice, and research. This included optic neuropathies with a focus on glaucoma. The open forums were especially valuable for clinicians to discuss their concerns and the opportunities that AI brings in delivering care to a greater cohort of ageing patients,” said Stephan Schulz, Heidelberg Engineering Clinical Director, Glaucoma.

Schulz underlined that the most pressing focus for all in glaucoma care is coping with the increasing number of cases, and identifying those who need specific care and those who need to be observed. Almost 50 percent of glaucoma patients can be missed – many will not experience problems, but others will quickly need attention.

The delegates and speakers explored issues surrounding AI’s potential in optic neuropathies, including

  • AI’s potential to enhance (not replace) clinicians.
  • How the use of AI to analyze images for visual biomarkers can support risk assessment, early disease detection, and treatment monitoring.
  • The importance of high-quality images and datasets for developing sensitive and accurate AI algorithms.
  • Advanced imaging techniques like OCTA, including multimodal data, to offer deeper insights into glaucomatous changes

This first industry-led glaucoma symposium comes 20 years on from the first International SPECTRALIS Symposium, also hosted by Heidelberg Engineering. Schulz explained that the company “has always had a strong position in glaucoma research and care, and it is fitting that this aspect of ophthalmology now has its own space in the conference arena. In the next five years we are expecting to see significant advances and […] new imaging devices, quite possibly to be used in the home.”
 

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: